Category Trading
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RVPHX | 10.37 | 0.10 | +0.97% |
| Royce Smaller-Companies Growth Invmt | |||
| STMSX | 27.91 | 0.26 | +0.94% |
| SEI Tax-Managed Small/Mid Cap F (SIMT) | |||
| FOVBX | 77.93 | 0.71 | +0.92% |
| Fidelity Advisor Overseas A | |||
| RGGRX | 23.59 | 0.16 | +0.68% |
| Victory RS Global R6 | |||
| TRICX | 5.01 | 0.03 | +0.60% |
| Catalyst/SMH Total Return Income C | |||
A.I.dvisor indicates that over the last year, CURE has been loosely correlated with QULL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CURE jumps, then QULL could also see price increases.
| Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
|---|---|---|---|---|
| CURE | 100% | +3.35% | ||
| QULL - CURE | 50% Loosely correlated | N/A | ||
| IFED - CURE | 33% Loosely correlated | +2.27% | ||
| TSLL - CURE | 30% Poorly correlated | +10.02% | ||
| MLPR - CURE | 26% Poorly correlated | -0.39% | ||
| SPXL - CURE | 23% Poorly correlated | +1.13% | ||
More | ||||
The Moving Average Convergence Divergence (MACD) for CURE turned positive on August 10, 2026. Looking at past instances where CURE's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on July 24, 2026. You may want to consider a long position or call options on CURE as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The 50-day moving average for CURE moved above the 200-day moving average on July 22, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CURE advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 244 cases where CURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for CURE moved out of overbought territory on August 20, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CURE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CURE broke above its upper Bollinger Band on August 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.